University of Zurich
π¨πSwitzerland
- Country
- π¨πSwitzerland
- Ownership
- Private
- Established
- 1833-04-29
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uzh.ch
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation
- Conditions
- DeathComplication
- Interventions
- Procedure: Liver transplantation
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2012-10-24
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 250
- Registration Number
- NCT01711957
- Locations
- π¨π
University Hospital Zurich, Department of Visceral Surgery and Transplantation, Zurich, Switzerland
Photodynamic Therapy for Ulcerative Colitis
Phase 1
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: Photodynamic therapy with Gliolan
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2012-11-04
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 7
- Registration Number
- NCT01697670
- Locations
- π¨π
Department of Gastroenterology and Hepatology, Zurich, Switzerland
Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.
- Conditions
- Solitary Fibrous Tumors of the Pleura
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2016-04-14
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 300
- Registration Number
- NCT01694654
- Locations
- π¨π
University Hospital Zurich, Division of Internal Medicine, Zurich, ZH, Switzerland
Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy
Phase 1
Completed
- Conditions
- Cholangiocellular Carcinoma
- Interventions
- Drug: Selective intra-arterial floxuridine and systemic gemcitabine and cisplatin
- First Posted Date
- 2012-09-25
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 12
- Registration Number
- NCT01692704
- Locations
- π¨π
University Hospital Zurich, Department of Oncology, Zurich, ZH, Switzerland
New Multiplex Real-time PCR for Genital Ulcer Disease
Completed
- Conditions
- Genital Ulcer Disease (GUD)
- First Posted Date
- 2012-09-19
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 50
- Registration Number
- NCT01688258
- Locations
- π¨π
University Hospital Zurich, Division of Dermatology, Zurich, ZH, Switzerland
Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
Completed
- Conditions
- Community-acquired Pneumonia
- First Posted Date
- 2012-09-11
- Last Posted Date
- 2014-05-28
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 122
- Registration Number
- NCT01683487
- Locations
- π¨π
University Hospital Zurich, Division of Internal Medicine, Zurich, ZH, Switzerland
Calcinosis Cutis: Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT)
Phase 3
Completed
- Conditions
- Calcinosis Cutis in Connective Tissue Disease
- Interventions
- Device: shock wave therapy with Modulith SLK (Storz)
- First Posted Date
- 2012-09-11
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 4
- Registration Number
- NCT01683500
- Locations
- π¨π
University Hospital Zurich, Division of Rheumatology, Zurich, ZH, Switzerland
vibroX-training in Endurance Trained Men
Not Applicable
Completed
- Conditions
- Health Behavior
- Interventions
- Other: vibrox- vs. resistance training
- First Posted Date
- 2012-08-24
- Last Posted Date
- 2013-05-14
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 30
- Registration Number
- NCT01672281
- Locations
- π¨π
University Hospital Zurich, Division of Neurology, Zurich, ZH, Switzerland
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
Phase 2
Completed
- Conditions
- Melanoma
- Interventions
- Drug: Pazopanib/Paclitaxel
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2018-10-16
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 19
- Registration Number
- NCT01666418
- Locations
- π¨π
University Hospital Zurich, Division of Dermatology, Zurich, Switzerland
Single-center Investigator Initiated Pilot Study Investigating the Tumor Response of Squamous Cell Carcinoma Lesions in Patients Under Lapatinib Treatment
- First Posted Date
- 2012-08-16
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 10
- Registration Number
- NCT01666431
- Locations
- π¨π
University Hospital Zurich, Division of Dermatology, Zurich, ZH, Switzerland
Β© Copyright 2025. All Rights Reserved by MedPath